Cite
HARVARD Citation
Vannata, B. et al. (2021). A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B‐cell lymphomas. Hematological oncology. 39 (1), pp. 60-65. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vannata, B. et al. (2021). A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B‐cell lymphomas. Hematological oncology. 39 (1), pp. 60-65. [Online].